logo-loader
FinanceFinancial Services
TP-ICAP PLC

End in sight for integration at TP ICAP after 'real progress' in 2018

Tullet Prebon, as it was called then, agreed to acquire ICAP in 2015 but integration has been a protracted process.

Stock market
Integration remains the key focus says TP ICAP

Derivatives broker TP ICAP PLC (LON:TCAP) is still working on integration of the ICAP broking business as impairments and write-offs sent profits sharply lower in 2018.

Tullet Prebon, as it was called then, agreed to acquire ICAP in 2015 but joining the companies has been a protracted process.

“By then end of 2018 we had spent £130mln on the integration process and we anticipate a total cost of integration of £160mln,” said Nicholas Breteau, TP ICAP’s chief executive.

"This is a significant amount of money and not all of it has been spent as effectively as it should have been. 

"However, it is necessary to spend to complete the integration so that we have a scalable platform from which to grow the business."

Breteau added good progress had been made over the past year though there is still work to do consolidating IT and data centres.

“We will complete the integration programme by the end of this year although activities to deliver further benefits from the ICAP acquisition will continue into 2020. “

Pre-tax profits fell 13% to £62mln in 2018, but that was after £183mln of restructuring. acquisition and goodwill costs.

Revenues rose slightly to £1.76bn.

Quick facts: TP-ICAP PLC

Price: £3.47

Market: LSE
Market Cap: £1.95 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

8 hours, 5 minutes ago

2 min read